Filter by
CGT-funded research shows resistant breast cancer in mice cured 60-90 percent with combination of two immunotherapies: Oncolytic viruses and checkpoint inhibitors
CURRENT ISSUE - March 2025
Embrace nonconforming work as opportunities for growth and improved lab performance